T1 eRx-QR
eRx-QR G
80/100
SUPPIE SCORE
78/100
EFFICACY
High
SAFETY
74/100
CLEANLINESS
What Does eRx-QR G Do?
This single-strain Saccharomyces boulardii product delivers a well-researched yeast at a standard dose commonly used in trials for reducing diarrhea duration and incidence during antibiotic use or travel.
How does this Saccharomyces boulardii strain compare to others for antibiotic-associated diarrhea?
Is this product suitable for children and what is the correct way to administer it?
What should I know about the lactose content before taking Yomogi?
Chat with Suppie
What Are the Benefits of eRx-QR G?
Based on proven scientific research
Diarrhea ReliefStrong
Traveler's DiarrheaModerate
Antibiotic-Associated DiarrheaStrong
Immune SupportMild
Gut Flora MaintenanceModerate
Good For:
What Are the Side Effects of T1 eRx-QR eRx-QR G?
Always consult your health practitioner if in doubt.
RiskLow Risk
Overview
•Contains 28.75 mg lactose per capsule; unsuitable for those with lactose intolerance or severe dairy allergy.
•Generally well-tolerated at labeled dose of 2.5-5 billion CFU daily; may cause mild gas in sensitive individuals.
•Rare risk of fungemia in severely immunocompromised patients or those with central venous catheters.
•No refrigeration required; stable formulation but consult healthcare professional if diarrhea persists beyond age-specific time limits.
•Avoid concurrent use with oral antifungal medications as they may reduce efficacy of the yeast.
•Safe for most adults and children over 2 years when label directions are followed.
Potential Side Effects
Negative Interactions
Allergens
LactoseGelatin (animal-derived)
Inactive Ingredients
Lactose
Medium RiskMagnesium stearate
Low RiskGelatin
Low RiskSodium dodecyl sulfate
Medium RiskChlorophyllin-copper complex
Low RiskTitanium dioxide
Medium RiskIron oxide hydrate
Low RiskWhat Are the Ingredients in T1 eRx-QR eRx-QR G?
Saccharomyces cerevisiae HANSEN CBS 5926 (synonym: Saccharomyces boulardii)
minimum 2.5 x 10^9 CFU in 250mg Lyophilisate
lactose
magnesium stearate
gelatin
sodium dodecyl sulfate
chlorophyllin-copper complex
titanium dioxide
iron oxide hydrate
Dosage & Bioavailability
How the active doses and forms in eRx-QR G compare to the research.
•Saccharomyces cerevisiae HANSEN CBS 5926 (synonym: Saccharomyces boulardii) is listed at minimum 2.5 x 10^9 CFU in 250mg Lyophilisate per serving; without a source-specific reference range, dose adequacy cannot be graded.
•Saccharomyces cerevisiae HANSEN CBS 5926 (synonym: Saccharomyces boulardii) has no distinct chemical or delivery form stated, so no product-specific absorption advantage can be established.
Sources & References
Yomogi
Information from www.mutaflor.com.au
Evidence
Information from www.yomogi.com.au
Yomogi saccharomyces cerevisiae boulardii hansen cbs 5926 cncm i 745 2 pack
Information from www.chemistwarehouse.com.au
PMC10418856
Information from pmc.ncbi.nlm.nih.gov
PMC7344949
Information from pmc.ncbi.nlm.nih.gov
Frequently Asked Questions
Common questions about T1 eRx-QR eRx-QR G